ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/09/28 | 1,540 | 1,554 | 1,518 | 1,553 | +8 | +0.5% | 366,400 |
2021/09/27 | 1,555 | 1,560 | 1,527 | 1,545 | -7 | -0.5% | 307,400 |
2021/09/24 | 1,515 | 1,556 | 1,511 | 1,552 | +67 | +4.5% | 526,300 |
2021/09/22 | 1,499 | 1,522 | 1,483 | 1,485 | -15 | -1% | 610,100 |
2021/09/21 | 1,483 | 1,518 | 1,480 | 1,500 | -63 | -4% | 721,400 |
2021/09/17 | 1,536 | 1,563 | 1,507 | 1,563 | +24 | +1.6% | 617,000 |
2021/09/16 | 1,618 | 1,627 | 1,533 | 1,539 | -97 | -5.9% | 984,800 |
2021/09/15 | 1,670 | 1,679 | 1,620 | 1,636 | -44 | -2.6% | 449,200 |
2021/09/14 | 1,656 | 1,686 | 1,648 | 1,680 | +22 | +1.3% | 426,600 |
2021/09/13 | 1,663 | 1,670 | 1,635 | 1,658 | -11 | -0.7% | 320,000 |
2021/09/10 | 1,663 | 1,671 | 1,632 | 1,669 | +34 | +2.1% | 539,700 |
2021/09/09 | 1,602 | 1,696 | 1,599 | 1,635 | +24 | +1.5% | 892,100 |
2021/09/08 | 1,593 | 1,620 | 1,583 | 1,611 | +17 | +1.1% | 375,400 |
2021/09/07 | 1,581 | 1,603 | 1,574 | 1,594 | +17 | +1.1% | 449,500 |
2021/09/06 | 1,580 | 1,589 | 1,563 | 1,577 | -3 | -0.2% | 481,300 |
2021/09/03 | 1,575 | 1,604 | 1,562 | 1,580 | +8 | +0.5% | 433,000 |
2021/09/02 | 1,616 | 1,619 | 1,566 | 1,572 | -33 | -2.1% | 407,400 |
2021/09/01 | 1,564 | 1,606 | 1,517 | 1,605 | +51 | +3.3% | 876,500 |
2021/08/31 | 1,595 | 1,604 | 1,543 | 1,554 | -43 | -2.7% | 839,900 |
2021/08/30 | 1,623 | 1,635 | 1,595 | 1,597 | -26 | -1.6% | 481,300 |
2021/08/27 | 1,596 | 1,627 | 1,573 | 1,623 | +29 | +1.8% | 496,400 |
2021/08/26 | 1,608 | 1,610 | 1,570 | 1,594 | +9 | +0.6% | 381,500 |
2021/08/25 | 1,605 | 1,610 | 1,556 | 1,585 | -12 | -0.8% | 615,900 |
2021/08/24 | 1,637 | 1,646 | 1,596 | 1,597 | -21 | -1.3% | 447,600 |
2021/08/23 | 1,617 | 1,642 | 1,602 | 1,618 | +6 | +0.4% | 447,400 |
2021/08/20 | 1,596 | 1,642 | 1,596 | 1,612 | +11 | +0.7% | 502,900 |
2021/08/19 | 1,621 | 1,643 | 1,586 | 1,601 | -33 | -2% | 616,100 |
2021/08/18 | 1,626 | 1,643 | 1,590 | 1,634 | -2 | -0.1% | 628,800 |
2021/08/17 | 1,587 | 1,658 | 1,579 | 1,636 | +58 | +3.7% | 617,400 |
2021/08/16 | 1,604 | 1,613 | 1,463 | 1,578 | -66 | -4% | 1,486,700 |
2021/08/13 | 1,636 | 1,666 | 1,625 | 1,644 | +8 | +0.5% | 588,400 |
2021/08/12 | 1,721 | 1,733 | 1,632 | 1,636 | -45 | -2.7% | 933,400 |
2021/08/11 | 1,682 | 1,705 | 1,661 | 1,681 | +13 | +0.8% | 657,900 |
2021/08/10 | 1,624 | 1,670 | 1,614 | 1,668 | +42 | +2.6% | 531,600 |
2021/08/06 | 1,649 | 1,678 | 1,605 | 1,626 | -29 | -1.8% | 670,000 |
2021/08/05 | 1,655 | 1,704 | 1,639 | 1,655 | +19 | +1.2% | 792,000 |
2021/08/04 | 1,695 | 1,698 | 1,617 | 1,636 | -63 | -3.7% | 878,300 |
2021/08/03 | 1,633 | 1,726 | 1,633 | 1,699 | +57 | +3.5% | 1,256,600 |
2021/08/02 | 1,634 | 1,666 | 1,583 | 1,642 | +56 | +3.5% | 1,199,200 |
2021/07/30 | 1,819 | 1,846 | 1,509 | 1,586 | -313 | -16.5% | 6,132,400 |
2021/07/29 | 1,872 | 1,906 | 1,854 | 1,899 | +50 | +2.7% | 600,400 |
2021/07/28 | 1,887 | 1,892 | 1,833 | 1,849 | -52 | -2.7% | 806,400 |
2021/07/27 | 1,934 | 1,945 | 1,894 | 1,901 | -27 | -1.4% | 516,400 |
2021/07/26 | 1,931 | 1,969 | 1,913 | 1,928 | +16 | +0.8% | 391,500 |
2021/07/21 | 1,933 | 1,954 | 1,903 | 1,912 | -11 | -0.6% | 463,500 |
2021/07/20 | 1,910 | 1,960 | 1,910 | 1,923 | -15 | -0.8% | 591,600 |
2021/07/19 | 1,964 | 1,979 | 1,933 | 1,938 | -53 | -2.7% | 534,100 |
2021/07/16 | 1,975 | 1,996 | 1,962 | 1,991 | +11 | +0.6% | 361,300 |
2021/07/15 | 2,014 | 2,020 | 1,980 | 1,980 | -34 | -1.7% | 481,300 |
2021/07/14 | 1,993 | 2,016 | 1,991 | 2,014 | +10 | +0.5% | 310,300 |
801~
850
件表示中 / 3612件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 340,500円 | +52.1% | +23.3% | 0.00% | 24.19倍 | 4.64倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
キッセイ薬 | 416,000円 | +14.5% | -2.3% | 2.16% | 15.22倍 | 0.81倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
東和薬品 | 335,500円 | +15.0% | -7.3% | 1.79% | 11.01倍 | 1.04倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
鳥居薬 | 471,500円 | +12.0% | +28.1% | 2.55% | 25.99倍 | 1.10倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 352,000円 | +3.0% | +27.5% | 2.27% | 22.28倍 | 0.97倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム